In the article titled “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.

The article notes: “The WHO fracture risk assessment tool (FRAX), a commonly used fracture prediction tool, has been found to underestimate fracture risk in the diabetic population [].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.